Prostate Cancer

A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer

This study is for the treatment of metastatic hormone-sensitive prostate cancer.

Primary disease category:

Secondary disease category(ies):

Cancer, Prostate Cancer

Study for treatment of castration resistant metastatic prostate cancer

Primary disease category:

Secondary disease category(ies):

Prostate Cancer